RT Journal Article
SR Electronic
T1 Distress, disease, desire: perspectives on the medicalisation of premature ejaculation
JF Journal of Medical Ethics
JO J Med Ethics
FD BMJ Publishing Group Ltd and Institute of Medical Ethics
SP 865
OP 866
DO 10.1136/medethics-2015-103248
VO 43
IS 12
A1 Söderfeldt, Ylva
A1 Droppe, Adam
A1 Ohnhäuser, Tim
YR 2017
UL http://jme.bmj.com/content/43/12/865.abstract
AB The discovery that certain selective serotonin reuptake inhibitors delay ejaculation and the later development and approval of dapoxetine as an on-demand treatment option has led to a dramatic increase in medical interest in premature ejaculation. This paper analyses the diagnostic criteria and the discussion within the medical community about suitable treatments against the backdrop of theories of science, sex and gender. Our conclusion is that the diagnosis itself and the suggested treatments contribute to normative models of sexual conduct and therefore reinforce the norms that cause patients' distress over ejaculating ‘too soon’.